- Home
- STRO vs KUKE Comparison
STRO vs KUKE Comparison
Compare STRO & KUKE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STRO
- KUKE
- Stock Information
- Founded
- STRO 2003
- KUKE 2002
- Country
- STRO United States
- KUKE China
- Employees
- STRO N/A
- KUKE N/A
- Industry
- STRO Biotechnology: Biological Products (No Diagnostic Substances)
- KUKE Other Consumer Services
- Sector
- STRO Health Care
- KUKE Real Estate
- Exchange
- STRO Nasdaq
- KUKE Nasdaq
- Market Cap
- STRO 77.7M
- KUKE 86.8M
- IPO Year
- STRO 2018
- KUKE 2021
- Fundamental
- Price
- STRO $0.76
- KUKE $2.90
- Analyst Decision
- STRO Hold
- KUKE
- Analyst Count
- STRO 7
- KUKE 0
- Target Price
- STRO $3.97
- KUKE N/A
- AVG Volume (30 Days)
- STRO 1.4M
- KUKE 8.8K
- Earning Date
- STRO 08-12-2025
- KUKE 07-31-2025
- Dividend Yield
- STRO N/A
- KUKE N/A
- EPS Growth
- STRO N/A
- KUKE N/A
- EPS
- STRO N/A
- KUKE N/A
- Revenue
- STRO $66,434,000.00
- KUKE $9,442,397.00
- Revenue This Year
- STRO N/A
- KUKE N/A
- Revenue Next Year
- STRO N/A
- KUKE N/A
- P/E Ratio
- STRO N/A
- KUKE N/A
- Revenue Growth
- STRO N/A
- KUKE N/A
- 52 Week Low
- STRO $0.52
- KUKE $1.45
- 52 Week High
- STRO $5.17
- KUKE $17.50
- Technical
- Relative Strength Index (RSI)
- STRO 44.92
- KUKE 41.21
- Support Level
- STRO $0.67
- KUKE $2.95
- Resistance Level
- STRO $0.79
- KUKE $3.03
- Average True Range (ATR)
- STRO 0.07
- KUKE 0.10
- MACD
- STRO -0.01
- KUKE 0.03
- Stochastic Oscillator
- STRO 34.52
- KUKE 47.60
About STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.
About KUKE Kuke Music Holding Limited
Kuke Music Holding Ltd provides classical music licensing, subscription, and education services in China. The company licenses its music content to online music entertainment platforms, such as Tencent Music Entertainment Group, digital music service providers, such as NetEase Cloud Music, as well as film and TV production companies, airlines, and smart hardware companies. Users can access the platform through the website, mobile app, and smart music devices.